[Masked diabetes insipidus manifested by administration of adrenocortical steroid hormone for erythroderma].
Ogawa
Noriko
N
Municipal Ohchi Hospital, Shimane.
Takamatsu
Toru
T
Miyake
Takaaki
T
Sota
Kazunari
K
Kato
Yuzuru
Y
D000281:Administration, Intranasal; D000309:Adrenal Insufficiency / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D000368:Aged; D000369:Aged, 80 and over; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage; D003873:Dermatitis, Exfoliative / Q000188:drug therapy / Q000209:etiology*; D020790:Diabetes Insipidus, Neurogenic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D007018:Hypopituitarism / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D011239:Prednisolone / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
D011239:Prednisolone; D003894:Deamino Arginine Vasopressin; D006854:Hydrocortisone